DIA Innovating Clinical Trials in Europe virtual conference will explore initiatives such as Accelerating Clinical Trials EU, European Health Data Space, and Digital Health Technologies. Dive into the groundbreaking potential of artificial intelligence (AI) in medicines development, reflect on the ethical considerations, ensuring fairness, privacy, and transparency, and gain insights into the regulatory perspectives and requirements. You will have the opportunity to learn how Real-World Evidence is transforming regulatory decision-making and putting patients at the center of discussions. Explore EU PEARL's master protocol studies in drug development and gain the knowledge and tools you need to stay ahead in this rapidly evolving field. Discover how Digital Health Technologies assist clinicians in facilitating identification, recruitment, and retention of patients, and explore the role of single-arm studies, standardization, and automation in innovative clinical trial design.
All of these are in the form of expert-led presentations, interactive panels, and thought-provoking sessions featuring the latest advancements in Clinical Trial Data. Register now for the DIA Innovating Clinical Trials in Europe!
Want to learn more about DIA Innovating Clinical Trials in Europe? You've come to the right site!
Álmath Spooner, PhD Head of Europe Regulatory Policy
Daniel Millar, MBA Senior Director, Strategic Business Transformation
Johnson & Johnson, United States
Elke Stahl, PhD Senior Expert, Clinical Trials Department
Federal Institute For Drugs and Medical Devices (BfArM), Germany
Jesper Kjær, MS Co-Chair, EMA/HMA Big Data Steering Group; Director of Data Analytics Centre
Danish Medicines Agency (DKMA), Denmark
Fia Westerholm, DVM, MSc Programme Assurance Manager
European Medicines Agency, Netherlands
Estelle Michael RWE Policy & External Engagement Lead
Have an account?